 Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
| Descriptor ID |
D003131
|
| MeSH Number(s) |
E02.186
|
| Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 0 | 4 | 4 | | 1984 | 0 | 12 | 12 | | 1985 | 0 | 13 | 13 | | 1986 | 0 | 13 | 13 | | 1987 | 0 | 13 | 13 | | 1988 | 0 | 10 | 10 | | 1989 | 0 | 18 | 18 | | 1990 | 0 | 22 | 22 | | 1991 | 0 | 10 | 10 | | 1992 | 0 | 16 | 16 | | 1993 | 0 | 28 | 28 | | 1994 | 0 | 24 | 24 | | 1995 | 0 | 37 | 37 | | 1996 | 0 | 21 | 21 | | 1997 | 0 | 19 | 19 | | 1998 | 0 | 30 | 30 | | 1999 | 0 | 33 | 33 | | 2000 | 0 | 23 | 23 | | 2001 | 1 | 34 | 35 | | 2002 | 0 | 24 | 24 | | 2003 | 0 | 36 | 36 | | 2004 | 1 | 42 | 43 | | 2005 | 1 | 32 | 33 | | 2006 | 1 | 26 | 27 | | 2007 | 1 | 41 | 42 | | 2008 | 1 | 46 | 47 | | 2009 | 1 | 47 | 48 | | 2010 | 0 | 47 | 47 | | 2011 | 0 | 43 | 43 | | 2012 | 0 | 31 | 31 | | 2013 | 0 | 30 | 30 | | 2014 | 1 | 35 | 36 | | 2015 | 2 | 27 | 29 | | 2016 | 0 | 42 | 42 | | 2017 | 0 | 39 | 39 | | 2018 | 1 | 34 | 35 | | 2019 | 1 | 41 | 42 | | 2020 | 0 | 29 | 29 | | 2021 | 0 | 22 | 22 | | 2022 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Ascierto PA, Warner AB, Blank C, Caracò C, Demaria S, Gershenwald JE, Khushalani NI, Long GV, Luke JJ, Mehnert JM, Robert C, Rutkowski P, Tawbi HA, Osman I, Puzanov I. The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021. J Transl Med. 2022 05 10; 20(1):200.
-
MacKinney EC, Holoubek SA, Khokar AM, Kuchta KM, Moo-Young TA, Prinz RA, Winchester DJ. Treatment differences at high volume centers and low volume centers in non-metastatic and metastatic adrenocortical carcinoma. Am J Surg. 2022 03; 223(3):582-586.
-
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. Am J Respir Crit Care Med. 2022 01 01; 205(1):17-35.
-
Cortés-Guiral D, Hübner M, Alyami M, Bhatt A, Ceelen W, Glehen O, Lordick F, Ramsay R, Sgarbura O, Van Der Speeten K, Turaga KK, Chand M. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021 12 16; 7(1):91.
-
Bleicher RJ, Moran MS, Ruth K, Edge SB, Dietz JM, Wilke LG, Stearns V, Kurtzman SH, Klein J, Yao KA. ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures. Ann Surg Oncol. 2021 12; 28(Suppl 3):572-573.
-
Brajcich BC, Benson AB, Gantt G, Eng OS, Marsh RW, Mulcahy MF, Polite BN, Shogan BD, Yang AD, Merkow RP. Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative. J Surg Oncol. 2022 Mar; 125(4):560-563.
-
Cui C, Chakraborty K, Tang XA, Schoenfelt KQ, Hoffman A, Blank A, McBeth B, Pulliam N, Reardon CA, Kulkarni SA, Vaisar T, Ballabio A, Krishnan Y, Becker L. A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours. Nat Nanotechnol. 2021 12; 16(12):1394-1402.
-
Pointer KB, Pitroda SP, Weichselbaum RR. Radiotherapy and immunotherapy: open questions and future strategies. Trends Cancer. 2022 01; 8(1):9-20.
-
Alali M, David MZ, Ham SA, Danziger-Isakov L, Pisano J. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever. J Pediatr Hematol Oncol. 2021 Oct 01; 43(7):e962-e971.
-
Turchan WT, Pitroda SP, Weichselbaum RR. Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future Focus. Clin Cancer Res. 2021 10 01; 27(19):5188-5194.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|